Blog

Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors

Photo taken from aacrjournals.org

Apr 26, 2024, 06:18

Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors

Aaron Goodman shared on X:

“This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors. Useful clinical stuff like time to onset and more.”

Additional information.
Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer Differentiation syndrome IDH1/2 inhibitors National Comprehensive Cancer Network NCCN OncoDaily Oncology University of California

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage